ABBV Shares Outstanding
Total shares outstanding each quarter, showing dilution from issuance or reduction from buybacks.
Shares Outstanding
Latest: 1.77B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 1.77B |
| 2020Q4 | 1.77B |
| 2021Q1 | 1.77B |
| 2021Q2 | 1.78B |
| 2021Q3 | 1.78B |
| 2021Q4 | 1.77B |
| 2022Q1 | 1.78B |
| 2022Q2 | 1.78B |
| 2022Q3 | 1.78B |
| 2022Q4 | 1.77B |
| 2023Q1 | 1.78B |
| 2023Q2 | 1.77B |
| 2023Q3 | 1.77B |
| 2023Q4 | 1.77B |
| 2024Q1 | 1.77B |
| 2024Q2 | 1.77B |
| 2024Q3 | 1.77B |
| 2024Q4 | 1.77B |
| 2025Q1 | 1.77B |
| 2025Q2 | 1.77B |
| 2025Q3 | 1.77B |
| 2025Q4 | 1.77B |
| 2026Q1 | 1.77B |
| 2026Q2 | 1.77B |
* In some reporting periods, diluted weighted-average shares are used instead of period-end shares outstanding. Please verify individual figures against the company's SEC filings.
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Shares Outstanding
Shares Outstanding
Shares Outstanding
Latest Shares Outstanding: 1.77B (2026Q2); -0.2% YoY; +0.7% CAGR since 2013Q1 (13.25y).
Across the 51 quarters from 2013Q1 to 2026Q2, Shares Outstanding ranged from 1.48B in 2019Q4 to 1.78B in 2022Q1.
Chart and table show the latest 24 of 51 quarters.